Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Biomaterials for blood-contacting applications

J M Courtney1, N M Lamba, S Sundaram

  • 1Bioengineering Unit, University of Strathclyde, Glasgow, UK.

Biomaterials
|August 1, 1994
PubMed
Summary

This study explores how biomaterials used in medical devices interact with blood. Researchers looked at factors like protein adsorption, platelet reactions, and coagulation. They found that these interactions are influenced by material structure, antithrombotic agents, and patient conditions. The study also examined different testing methods, suggesting that ex vivo and in vitro approaches are most useful during development. The researchers propose that future work should focus on improving in vitro models to better predict how materials will behave in the body. The study highlights the complexity of blood-biomaterial interactions and the need for careful evaluation methods.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A platelet counting technique to study platelet aggregation in whole blood: application to pathologically low platelet counts.

Platelets·2010
Same author

Effective inhibition of platelet aggregation in whole blood with a combination of dipyridamole and iloprost.

Platelets·2010
Same author

Prevention of fibrinolytic shut-down after major surgery by intramuscular stanozolol.

Thrombosis research·2010
Same author

Quality of life and inflammation in exacerbations of bronchiectasis.

Chronic respiratory disease·2008
Same author

Predictors of mortality in adults with cystic fibrosis.

Pediatric pulmonology·2007
Same author

Cytokines and inflammatory mediators in cystic fibrosis.

Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society·2005

Area of Science:

  • Biomaterials engineering
  • Hematology
  • Medical device development

Background:

Uncertainty remains about how biomaterials interact with blood components. Prior research has shown that blood responses depend on multiple factors, including material properties and clinical conditions. No prior work had resolved the full range of interactions between blood and implanted materials. Researchers have identified protein adsorption and platelet reactions as key areas of interest. However, the role of complement activation and fibrinolytic activity is less understood. This gap motivated the need for a comprehensive review of blood-biomaterial interactions. The study aimed to clarify which evaluation methods are most suitable for material development. Understanding these interactions is essential for improving the safety of blood-contacting devices.

Purpose Of The Study:

The goal was to assess how blood interacts with biomaterials used in medical devices. Researchers wanted to identify the key factors that influence these interactions. They also aimed to evaluate the most effective testing methods for new materials. The study focused on interactions involving proteins, platelets, and coagulation factors. The motivation came from the need to improve the biocompatibility of blood-contacting devices. The researchers considered clinical, in vivo, and in vitro approaches. They wanted to determine which methods are most useful during the development phase. The study aimed to provide a framework for future biomaterial design and testing.

Keywords:
biomaterialsblood compatibilitymedical device testingin vitro methods

Frequently Asked Questions

The researchers propose that protein adsorption is the primary mechanism, followed by platelet reactions and coagulation pathway activation.

The study suggests that material structure, antithrombotic agents, patient health, and application type all influence blood responses.

The researchers propose that these methods allow for controlled testing and early-stage material refinement before clinical trials.

The study suggests that this pathway is a key factor in determining how blood clots form on material surfaces.

Related Experiment Videos

Main Methods:

The researchers reviewed existing literature on blood-biomaterial interactions. They analyzed how proteins adsorb onto different material surfaces. They also examined how platelets respond to various biomaterials. The team considered the role of the intrinsic coagulation pathway in material interactions. They looked at how fibrinolytic activity affects blood responses. The researchers evaluated the impact of erythrocytes and leucocytes on material performance. They also assessed the influence of complement activation. The study compared clinical, in vivo, and in vitro testing methods for their relevance.

Main Results:

Protein adsorption was found to be a primary factor in blood-biomaterial interactions. Platelet reactions were shown to vary depending on the material surface. The intrinsic coagulation pathway was identified as a key player in material response. Fibrinolytic activity was found to influence clot formation and dissolution. Erythrocyte and leucocyte interactions were less well understood. Complement activation was shown to affect inflammation and immune response. The presence of antithrombotic agents was found to modify blood responses. Ex vivo and in vitro methods were highlighted as useful for material development.

Conclusions:

The study suggests that blood-biomaterial interactions are complex and multifactorial. The researchers propose that protein adsorption and platelet reactions are central to material performance. They suggest that the intrinsic coagulation pathway plays a significant role in device function. The study proposes that fibrinolytic activity should be considered in material design. The researchers suggest that patient status and drug therapy influence blood responses. They propose that ex vivo and in vitro methods are most suitable for early development. The study suggests that clinical testing remains necessary for final validation. The researchers propose that future work should focus on refining in vitro models.

The researchers propose that these cells contribute to inflammation and immune response, though their exact role is less well understood.

The study suggests that future work should focus on refining in vitro models to better predict clinical performance.